Wellcome Sanger Institute

JUNO: A global genomic survey of Streptococcus agalactiae

JUNO project is a global genomic surveillance study of Streptococcus agalactiae with the central aim of informing disease intervention strategies.

About the Collaboration

Group B Streptococcus (GBS, a.k.a. Streptococcus agalactiae) is an opportunistic pathogen and a major cause of neonatal invasive disease, with a particular impact on infant mortality in low and middle-income countries (LMICs). We will conduct whole genome sequencing of GBS isolates from across a broad geographical and temporal span to better understand pathogen diversity, pathogen genetic association with the disease and pathogen transmission. The analysis outputs will serve to inform future disease prevention and treatment strategies.

The generated data will be made freely available through open online platforms.


If you need help or have any queries, please contact us using the details below.

Sanger people

Photo of Professor Dominic Kwiatkowski

Professor Dominic Kwiatkowski

Head of Parasites and Microbes Programme and Senior Group Leader

Photo of Sonia Goncalves

Sonia Goncalves

Head of Service Delivery - Genomic Surveillance

External partners and funders